Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-12

Clinical Trial Update: SWIFT - SWIss Factor XIII Trial in PPH [Phase 4]

View source ↗

Summary

Phase 4 clinical trial SWISS Factor XIII in Postpartum Hemorrhage is currently recruiting to evaluate factor XIII concentrate for this condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Factor XIII concentrate (Coagulation factor XIII concentrate)

Snippet

Sponsor: Christian Haslinger | Conditions: Postpartum Hemorrhage, Coagulation Disorder | Phase 4 | Status: RECRUITING